ABSTRACT Background: Weight loss leads to reduced resting energy expenditure (REE) independent of fat-free mass (FFM) and fat mass (FM) loss, but the effect of changes in FFM composition is unclear. Objective: We hypothesized that a decrease in REE adjusted for FFM with weight loss would be partly explained by a disproportionate loss in the high metabolic activity component of FFM. Design: Forty-five overweight and obese women [body mass index (in kg/m 2 ): 28.7-46.8] aged 22-46 y followed a low-calorie diet for 12.7 6 2.2 wk. Body composition was measured by magnetic resonance imaging, dual-energy X-ray absorptiometry, and a 4-compartment model. REE measured by indirect calorimetry (REEm) was compared with REE calculated from detailed body-composition analysis (REEc) by using specific organ metabolic rates (ie, organ REE/mass). Results: Weight loss was 9.5 6 3.4 kg (8.0 6 2.9 kg FM and 1.5 6 3.1 kg FFM). Decreases in REE (28%), free triiodothyronine concentrations (28%), muscle (23%), heart (25%), liver (24%), and kidney mass (26%) were observed (all P , 0.05). Relative loss in organ mass was significantly higher (P , 0.01) than was the change in low metabolically active FFM components (muscle, bone, and residual mass). After weight loss, REEm 2 REEc decreased from 0.24 6 0.58 to 0.01 6 0.44 MJ/d (P = 0.01) and correlated with the decrease in free triiodothyronine concentrations (r = 0.33, P , 0.05). Women with high adaptive thermogenesis (defined as REEm 2 REEc , 20.17 MJ/d) had less weight loss and conserved FFM, liver, and kidney mass. Conclusions: After weight loss, almost 50% of the decrease in REEm was explained by losses in FFM and FM. The variability in REEm explained by body composition increased to 60% by also considering the weight of individual organs.
INTRODUCTION
Evidence exists that weight loss leads to a reduction in resting energy expenditure (REE) beyond that explained by losses in fatfree mass (FFM) and fat mass (FM) (1) (2) (3) (4) (5) (6) . Decreases in specific REE (ie, the decrease in REE beyond what could be predicted from the changes in FM and FFM) have been described as "adaptive thermogenesis" (7) . Some authors considered adaptive thermogenesis a transient phenomenon that is at least partly explained by a weight loss-induced reduction in serum triiodothyronine concentrations (T 3 ) (8-10), whereas others suggest a persistence of reduced specific REE after weight loss (2, 4, (11) (12) (13) (14) (15) (16) (17) . Because a decline in specific metabolic rate may predispose to regain of lost weight (18, 19) , the metabolic response may be maladaptive in the case of intended weight loss.
FFM consists of water, protein, and minerals and is the major determinant of REE that explains 60-80% of the interindividual variance in REE. FM, comprising all body lipids, also contributes to REE variance, especially when subjects with a large range in body mass index (in BMI; kg/m 2 ) are investigated (20) . Because FFM and FM are chemically defined, this 2-compartment model may be insufficient when adjusted for intraindividual differences in REE after weight loss. In contrast, functional body-composition analysis at the organ and tissue level adds to our understanding of interindividual variance in REE (21) (22) (23) (24) (25) (26) (27) . Brain, heart, liver, and kidneys comprise only 5-6% of body weight, but contribute to .80% of REE (28) , whereas other components such as muscle, adipose tissue, or bone mass have low specific resting metabolic rates.
Little is known about changes in the composition of lean mass during weight loss. In severely obese humans (BMI: 47.3 6 5.3) after a very-low-energy diet for 12 wk, the relative decrease in liver volume exceeded the mean loss in body weight (218.7% compared with 210.6%) (29) . These findings raise the possibility that weight loss-associated adaptive thermogenesis is partly explained by higher losses in high metabolic activity organs when compared with lower specific metabolic rate tissues.
The aim of this study was to investigate the contribution of decreases in the mass of individual metabolically active organs to adaptive thermogenesis by using REE modeling from detailed body-composition analysis in healthy overweight and obese women before and after weight loss. We hypothesized that a decrease in REE adjusted for FFM with weight loss would be partly explained by a disproportionate loss in the high metabolic activity component of FFM. In addition to magnetic resonance imaging (MRI) for the assessment of organs, we have used a 4-compartment model to measure body FM.
SUBJECTS AND METHODS

Study protocol
During December 2006 to June 2008, 69 healthy premenopausal overweight and obese white women aged 22-41 y were recruited by notice board posting and advertisement in the local newspaper to undergo a diet-induced weight-loss program. Women selected for participation met the following inclusion criteria: normal results from a physical examination and an echocardiogram; no use of lipid-lowering, hypoglycemic. or antihypertensive medication; no history of cardiovascular or metabolic disease; and normal thyroid function. Twelve women dropped out because of orthopedic operations (2 cases), personal reasons (4 cases), and unsuccessful weight loss (6 cases). Data from 10 subjects with a weight loss ,5 kg were excluded, because the resulting loss in lean mass ,0.8 kg was too low to be assigned to losses in individual organ masses. Resistance to weight loss in these subjects was not caused by high adaptive thermogenesis (T1 2 T0 differences in REE adjusted for FFM and REE adjusted for FFM and FM were 20.29 and 20.22 MJ/d; NS for both). Data from an additional 2 subjects were excluded because of respiratory artifacts in abdominal images. The remaining data from 45 women (2 overweight with a BMI .25 and 43 obese with a BMI .30; BMI range: 28.7-46.8) were included in this study. The study was approved by the medical ethics committee of the Christian-Albrechts-University Kiel. All subjects provided their fully informed and written consent before participation.
Weight-loss intervention
During 12.7 6 2.2 wk of weight-loss intervention, subjects consumed a low-calorie, nutritionally balanced diet containing 800-1000 kcal/d; 434 kcal/d was supplied as a very-low-energy diet (BCM-Diät; PreCon, Darmstadt, Germany). Ingestion of 2 shakes/d provided all nutrients according to the Recommended Dietary Allowance, 37.3 g protein, 38.8 g carbohydrate, and 13.5 g fat. Women were instructed to choose a third low-fat meal containing mainly vegetables, meat, or fish and a maximum of 400 kcal/d. In addition, 7 bonus portions of 100 kcal/d each were allowed during the week to be self-allocated. All women obtained weekly individual counseling in the principles of the hypocaloric diet by a registered dietitian. Compliance was monitored by occasional 3-d food records and weekly measurement of losses in weight and FM by air-displacement plethysmography (BOD-POD; Life Measurement Inc, Concord, CA). At the end of the intervention period, 43 subjects were weight stable, defined as weekly weight change in the past 2 wk of intervention , 61 kg (mean weekly rate of weight change over the past 2 wk was 20.08 6 0.52 kg). The remaining 2 subjects were still losing 1.65 and 2.70 kg/wk. Because the exclusion of these 2 subjects did not change the results they were included in the final analysis.
Clinical and metabolic variables
Fasting serum concentrations of thyrotropin (TSH), free T 3 , and free thyroxine (T 4 ) were measured by radioimmunoassay (RIA; DiaSorin, Dietzenbach, Germany); the intra-and interassay CVs were 2.5% and 5.7% (TSH), 4.6% and 6.5% (T 3 ), and 2.4% and 6.8% (T 4 ). The sensitivity limits were 0.02 mIU/mL (TSH), 0.35 pg/mL (T 3 ), and 1 pg/mL (T 4 ), respectively. Plasma insulin was measured by RIA showing no cross-reactivity with C-peptide and only 14% with proinsulin (Adaltis, Rome, Italy). Plasma glucose was assayed by using a hexokinase enzymatic method. The homeostasis model assessment of insulin resistance (HOMA-IR) was calculated as fasting insulin (lU/mL) · fasting glucose (mmol/L)/22.5 (30) . RIA test kits from LINCO Research (MO) using the doubly-antibody/polyethylene glycol technique were used for the measurement of serum leptin and adiponectin. Analytic sensitivity and the intra-and interassay CVs were 0.5 ng/mL, 3-8%, and 4-8% for leptin and 1 ng/mL, 2-6%, and 7-9% for adiponectin, respectively. Blood pressure measurements were obtained while the subjects were in a seated position with the use of a standard manual sphygmomanometer.
Body composition
Magnetic resonance imaging
Volumes of internal organs were assessed by MRI with a Magnetom Avanto 1.5-T scanner (Siemens Medical Systems, Erlangen, Germany). Subjects were examined in a supine position with their arms extended above their heads. Transversal images were obtained from wrist to ankle. Only images from the head, abdominal and thoracic regions were included in the present analysis by using a contiguous axial T1 weighted gradient-echo sequence [repetition time (TR): 157 ms; time to echo (TE): 4 ms; flip angle: 70°; voxel size: 3.9 · 2 · 8 mm 3 ]. The protocol for the brain comprised contiguous 4-mm slices with 1-mm interslice gaps (TR: 313 ms; TE: 14 ms). For the rest of the body, images were obtained with 8-mm slice thickness and 2-mm interslice gaps. Image acquisition for volumetric assessment of the abdominal region was obtained in breath-hold, and left ventricular mass was assessed using a breath-navigated and pulse-triggered T2-weighted HASTE sequence (TR: 700 ms; TE: 24 ms; flip angle: 160°; slice thickness: 8 mm; interslice gap: 2 mm; voxel size: 2.2 · 1.3 · 8 mm 3 ; turbo factor: 106). All images were segmented manually (Tomovision 4.3 Software; Slice-O-Matic, Montreal, Canada), and each organ was analyzed by the same observer who was blinded to the time point and subject identity (intraobserver CVs based on comparison of repeated segmentations were 1.8% for brain, 0.07% for liver, 1.7% for heart, and 1.0% for kidneys). Total organ volume was determined from the sum of all areas (cm 2 ) multiplied by the slice thickness. Volume data were transformed into organ mass by using the following densities: 1.036 g/cm 3 for brain, 1.06 g/cm 3 for heart and liver, and 1.05 g/cm 3 for kidneys (31) . Left ventricular mass was multiplied by a factor of 1.50 to obtain a value for total heart mass (32) .
In a subgroup of 24 subjects liver fat was quantified by singlevoxel proton magnetic resonance spectroscopy ( 1 H-MRS). A cubic voxel with an edge length of 2 cm was set in the ventral part of the liver by carefully avoiding the inclusion of major blood vessels and fatty infiltrations. Spectra were acquired with a stimulated echo pulse sequence with the following parameters: TE of 15 ms, TM of 10 ms, and TR of 4 s. The sequence included 8 dummy scans followed by 32 repetitions, resulting in a total scan time of 160 s. Phasing of the raw spectra was done with the jMRUI software package (33) . Subsequently, ORIGIN (OriginLab, Northampton, MA) was used for data fitting. The intrahepatocellular lipid fraction was determined by dividing the integrated lipid signal by the sum of the integrated lipid and water signals [IHCL = S lipid /(S lipid + S water )]. Liver fat was quantified by using algorithms proposed by Longo et al (34) .
Four-compartment model
FM was calculated from body volume (by air-displacement plethysmography), total body water (TBW by deuterium dilution), and bone mineral content (BMC by dual-energy X-ray absorptiometry) by using the equation of Fuller et al (35) A detailed description of each method and its precision was previously reported (36) . FFM was calculated as the difference between body mass and FM. Air-displacement plethysmography was performed by using the BOD-POD device (Life Measurement Instruments). Before each measurement, a 2-step calibration was carried out. Two repeated body volume measurements were performed, averaged, and corrected for predicted body surface area and thoracic gas volume was measured by using the BODPOD software (version 1.69). The CV for repeated body volume measurements was 0.2%. Dual-energy X-ray absorptiometry was performed to measure BMC as well as lean soft tissue from the arms and legs with a Hologic Discovery A densitometer and the whole-body software 12.6.1:3 (Hologic Inc, Bedford, MA).
Deuterium dilution was used to analyze TBW. After a 40-mL venous blood sample was collected, each participant received an oral dose of 0.4 g deuterium oxide (99.8%; Carl Roth GmbH, Karlsthal, Germany) per kg body weight with an amount of 100 mL tap water. Four hours later, a second blood sample was collected. The concentration of deuterium oxide was measured in ultrafiltrate by Fast-Fourier infrared spectroscopy (Digilab, Holliston, MA) equipped with a CaF 2 sample cell (Omnicell Specac Ltd, Orpington, United Kingdon). The CV for repeated TBW measurements was 1.2%.
Resting energy expenditure
Indirect calorimetry was performed in the morning between 0730 and 0900 after an overnight fast (ventilated hood system Vmax Spectra 29n; SensorMedics BV, Bilthoven, Netherlands; software Vmax, version 12-1A). The subjects arrived at the Institute for Human Nutrition and Food Science, where the measurement was made in a metabolic ward at constant temperature and humidity. The minimum duration of the measurement was 45 min and the first 10 min was discarded. Flow calibration was performed with a 3-L syringe, and gas analyzers were calibrated before and every 5 min during the run. Data were collected every 20 s and acquired oxygen volume and carbon dioxide volume were converted to REE (kcal/24 h) by using the abbreviated equation of Weir. For each subject, REE was measured 4 times on 2 different mornings before (T0) and after (T1) the intervention. The results of both measurements at each time point were averaged. The CVs for repeated REE measurements were 5.2% at T0 and 4.3% at T1. All women were studied at the follicular phase of the menstrual cycle.
Calculation of REE (REEc) was based on the sum of 8 body compartments (brain, heart, liver, kidneys, skeletal muscle mass, bone mass, adipose tissue, and residual mass) times the corresponding tissue respiration rate using the specific tissue metabolic rates reported by Elia (28) . For bone mass, a specific metabolic rate of 9.63 kJ Á kg 21 Á d 21 was assumed (37) . Residual mass was calculated as body mass minus the sum of brain, heart, liver, kidneys, skeletal muscle mass, bone mass, and adipose tissue. The metabolic activity of residual mass was assumed to be 30 kJ Á kg 21 Á d 21 (22) .
REEc ðkJ=dÞ ¼ ð1008 3 brain massÞ þ ð840 3 liver massÞ þ ð1848 3 heart massÞ þ ð1848 3 kidney massÞ þ ð55 3 skeletal muscle massÞ þ ð9:63 3 bone massÞ þ ð19 3 adipose tissueÞ þ ð30 3 residual massÞ ð 2Þ
Adipose tissue was calculated from FM assuming a fat content of 90%. Skeletal muscle mass was calculated from the sum of lean soft tissue from arms and legs by using the equation of Kim et al (38) . Bone mass was calculated by multiplying BMC by 1.85 based on reference man data (39) . Adaptive thermogenesis was defined as weight loss-induced decreases in REE adjusted for FFM and FM as well as measured REE minus REE calculated from organ and tissue mass (REEm-REEc).
Statistical methods
Data are presented as means 6 SDs. Variables that did not meet the criteria of normal distribution (Shapiro-Wilk test of normality) and homogeneity of the variances were insulin and leptin concentrations, HOMA-IR, blood pressure, and changes in T 3 concentrations. Within-group differences between preintervention and postintervention measures of variables were determined by using a paired Student's t test or Wilcoxon's nonparametric test, depending on the distribution of the data. Between-group comparisons of subjects with high and low adaptive thermogenesis (retrospectively defined relative to the median of REEm-REEc T1 2 T0 20.17 MJ/d to facilitate sufficient numbers for between-group comparison) were analyzed with a Mann-Whitney U test. REE was adjusted for FFM and FM by using regression analysis. Relations between variables were sought by correlation analysis (Pearson's and Spearman's r). Statistical significance was set at P , 0.05. Data analyses were performed with SPSS statistical software (version 13.0; SPSS Inc, Chicago, IL).
RESULTS
Body composition
Subject characteristics at baseline and weight loss-induced changes after 12.7 6 2.2 wk of follow-up are shown in Table 1 . Mean weight loss was 9.5 6 3.4 kg (3.9%), consisting of 8.0 6 2.9 kg FM (17.5%) and 1.5 6 3.1 kg FFM (2.6%). Relative ORGAN MASS LOSS WITH WEIGHT LOSS changes in organ weights were 25.2% for heart mass, 26.1% for kidney mass, and 24.4% for liver mass, whereas brain mass remained stable in mass during weight loss (0.4%). Mean relative losses in high compared with low metabolically active FFM components [23.1 6 6.0% for all organ masses compared with þ1.4 6 6.3% for muscle (23.1%), bone (1.3%), and residual mass (2.1%)] were significantly different (P = 0.001). The sum of the decrease in liver, heart, and kidney mass was 113 g. Significant losses in lean soft tissue from arms and legs resulted in a mean loss of 923 61666 g (3.2%) skeletal muscle mass. Altogether, '1 kg of the 1.5-kg decrease in FFM was explained by muscle and organ mass. The remaining 0.5 kg decrease in FFM was likely due to a loss in the lean component of adipose tissue, bone, gastrointestinal tract, skin, and other unmeasured components in addition to measurement error. There was no significant change in residual mass with weight loss (14.5 6 4.3 kg at baseline compared with 14.8 6 3.4 kg; P = 0.58).
Resting energy expenditure
Decreases in organ mass were not significantly correlated with each other or with the change in FFM. By contrast, the decrease in leg lean soft tissue was associated with the decrease in FFM (r = 0.40, P , 0.001). The decrease in liver mass correlated with decreases in FM (r = 0.50, P , 0.001), body weight (r = 0.69, P , 0.001), and BMI (r = 0.65, P , 0.001).
Weight loss led to a decrease in REEm of 20.57 6 0.64 MJ/d (Table 1) . After adjustment for the decreases in FFM and FM, the change in REE was reduced to 20.30 6 0.57 MJ/d. The calculation of REE from organ and tissue mass (REEc) was 7.12 6 0.82 MJ/d before weight loss and 6.79 6 0.77 MJ/d after weight loss (P , 0.001). When compared with baseline, the difference between REEm and REEc was only 20.23 6 0.65 MJ/d lower after weight loss. However, this difference remained statistically significant at P = 0.02. The relation between baseline and follow-up in REE adjusted for FFM+FM and REEm-REEc is shown in Figure 1 , A and B. In Figure 2 , the relation between REEm and REEc is shown for each study period.
Blood pressure and hormones
Weight loss was associated with significant decreases in systolic blood pressure (125 6 11 compared with 119 6 9 mm Hg; P , 0.001) and diastolic blood pressure (81 6 10 compared with 75 6 7 mm Hg; P , 0.001) as well as decreases in serum T 3 , insulin, HOMA-IR (Table 1) , and leptin concentrations (47.57 6 24.16 compared with 27.60 6 14.16 ng/mL; P , 0.001), whereas there was no change in serum T 4 , TSH (Table 1) , and adiponectin concentrations (11.48 6 5.18 compared with 11.48 6 5.64 lg/mL; P = 0.99).
Associations with REE
At baseline, REEm-REEc and REE adjusted for FFM+FM correlated with heart mass (r = 20.44 and r = 20.33, both P , 0.05) and HOMA-IR (r = 0.32 and r = 0.30; both P , 0.05), whereas REEm-REEc also correlated with serum T 3 (r = 0.30, P , 0.05) and glucose concentrations (r = 0.34, P , 0.05). After weight loss, REEm-REEc correlated with heart mass only (r = 20.32, P , 0.05). There were significant correlations between weight loss-induced reductions in REE adjusted for FFM+FM or REEmREEc and decreases in serum T 3 concentrations (r = 0.33 and r = 0.31, both P , 0.05) and decreases in muscle mass (r = 0.31, P , 0.05 for REE adjusted for FFM+FM only). The decrease in REE adjusted for FFM+FM also correlated with the decrease in insulin concentrations (r = 0.30, P , 0.05). No other correlations between weight loss-induced reductions in REE variables and changes in body-composition estimates, leptin concentrations, or leptin/FM were observed.
High compared with low adaptive thermogenesis
The weight loss-induced difference in REEm-REEc showed considerable interindividual variation ( Figure 1B) . Therefore, the study population was divided into 2 groups according to their weight loss-induced changes in REEm-REEc. Subjects with REEm-REEc T1 2 T0 , 20.17 MJ/d (median of the population) were classified as having high "adaptive thermogenesis," whereas subjects with REEm-REEc T1 2 T0 ! 20.17 MJ/d were classified as having "low adaptive thermogenesis" ( Table 2) . At baseline, subjects with high adaptive thermogenesis had a higher REE adjusted for FFM+FM as well as REEm-REEc when compared with subjects with low adaptive thermogenesis, but no between-group differences in the other variables were found. Subjects with high adaptive thermogenesis had smaller losses in body weight, and BMI. FFM and liver and kidney mass were all preserved in subjects with high adaptive thermogenesis. There were no T0, T1, or delta T1-T0 between-group differences in basal insulin, adiponectin, or leptin concentrations or HOMA-IR (data not shown). However, subjects with a high adaptive thermogenesis tended to have a greater decrease in serum T 3 concentrations (P = 0.058; Table 2 ). In this subgroup adaptive thermogenesis correlated with decreases in basal insulin concentrations and HOMA-IR (r = 0.61 and r = 0.61 for correlation with T1-T0 changes in REE adjusted for FFM+FM ; both P , 0.01 and r = 0.48 and r = 0.48 for correlation with T1-T0 changes in REEm-REEc; both P , 0.05).
Liver fat content
The subgroup of 24 women who had an examination of liver fat by 1 H-MRS were significantly younger (30.1 6 5.9 compared with 36.0 6 6.4 y; P , 0.05), had a larger heart mass at baseline (248 6 43 compared with 214 6 47 g; P , 0.05), and had a smaller loss in muscle mass (20.36 6 1.78 compared with 21.57 6 1.28 kg; P , 0.05) when compared with the remaining 21 subjects. All other measures of body composition, energy expenditure, or hormone concentration were not different from the rest of the study population. The weight loss-associated reduction in liver fat was 266.5 6 91.5 g and ranged from 2312 to 41 g. The loss in liver fat correlated with the loss in liver mass (r = 0.44, P . 0.05). Losses in liver mass and fat did not differ between subjects with high (n = 11) and low (n = 13) adaptive thermogenesis (2136 6 104 compared with 2150 6 195 g; P = 0.07 for liver mass and 268.4 6 92.9 compared with 264.9 6 94.1 g; P = 0.92 for liver fat).
DISCUSSION
A 10% weight loss in overweight and obese women led to a considerable decrease in REEm (20.57 MJ/d; 7.7%). Almost one-half (0.27 MJ/d; 47%) of this decrease was explained by losses in FFM and FM, whereas changes in individual organ weights and tissue mass increased the fraction of the variability in changes in REEm that is explained by body composition to 60% (0.34 MJ/d; Table 1 ; ie, an absolute increase of 10%). Thus, '40% of the decrease in REE with weight loss can be ascribed to adaptive thermogenesis. The decrease in metabolic rate not explained by a loss in organ and tissue mass (ie, REEm-REEc) was 20.23 MJ/d (Table 1) , which is 23.2% of baseline REE. The importance of this magnitude of adaptive thermogenesis becomes evident from the calculation that an increase in body mass of 1 kg/y corresponds to an energy imbalance ,80 kJ/d (40) . If uncompensated by a lower energy intake, adaptive thermogenesis could thus result in a weight gain of '3 kg/y.
As for the determinants of adaptive thermogenesis, the positive relation between REEm-REEc and glucose concentrations or HOMA-IR at baseline may partly explain the higher specific metabolic rate in our subjects. Likewise, in the 23 women with high adaptive thermogenesis, weight loss-induced changes in REE adjusted for FFM+FM and REEm-REEc showed a high correlation with decreases in basal insulin concentrations and HOMA-IR. Earlier studies also reported an association between REE and plasma insulin concentrations, insulin resistance, or glycemia (41) (42) (43) . Insulin resistance may lead to a higher REE by increasing protein turnover, futile cycling, gluconeogenesis, and the activity of the sympathetic nervous system (for a review see 42). Direct evidence for a reduction in specific metabolic rate with weight loss highlights the underlying mechanisms of adaptive thermogenesis. Raben et al (12) showed lower activity of oxidative key enzymes and smaller fiber areas in the skeletal muscle of postobese women. In rats, 50% food restriction over a period of 3 d led to weight loss of 25% and decreases in the ratio of liver to body mass of 7% (44) . In addition, liver mitochondria in the food-restricted animals showed diminished state 3 (230%), state 4-oligomycin (226%), and uncoupled state (224%) respiration rates. The authors concluded that rats not only adapt to food restriction through simple passive mechanisms, such as liver mass loss, but also through a decrease in mitochondrial energy metabolism. The same group extended their studies to calorie-restricted obese humans, who also showed a greater efficiency of ATP synthesis with a lower proton leak (45) . There is a role of thyroid hormones in mitochondria thermogenesis (46; Table 1 and Table 2 ), and a decrease in serum T 3 concentrations with weight loss (8-10) and low serum T 3 concentrations were observed in normal-weight postobese subjects with a lower REE (47) . In addition, in subjects with high adaptive thermogenesis, a greater decline in T 3 during weight loss might have caused a conservation of lean mass (eg, organ mass) ( Table 2) . A correlation between thyroid hormones and nitrogen balance has been known for almost 40 y (48, 49) and was confirmed in the bed rest model of simulated weightlessness, with T 3 supplementation leading to increased protein breakdown and losses of lean mass and body weight (50) . The ability to decrease serum T 3 concentrations during caloric restriction was suggested to be critical for achievement of an adaptational decrease in protein loss (51) . However, the inverse correlation between decreases in T 3 and FFM was not statistically significant (r = 20.26, P = 0.09).
Effect of weight loss-associated changes in FFM composition
In our study population, a '10% weight loss was associated with changes in high metabolic activity organ weights (liver, heart, and kidneys) of between 4% and 6%, which exceeded the loss in total FFM (2.6%). In contrast, no change was observed for brain mass (Table 1) . However, brain mass is known to decrease after severe weight loss in patients with anorexia nervosa, who have a predominant loss in gray matter that is reversible after nutritional recovery (52) . In underweight women, the lower organ mass explained the lower REE adjusted for FFM compared with that in normal-weight subjects (23) . Weight regain after weight loss may further reduce the specific metabolic rate of FFM, because trunk lean mass decreased with weight loss, but contrary to leg lean mass, it was not regained during weight regain (53) . This may reflect a reduction in organ mass with weight cycling.
To our knowledge, only 3 studies have examined the changes in liver volume after weight loss in humans (29, 54, 55) . In these studies, the decrease in liver size was found to be 1) enhanced in subjects with larger initial liver mass (29) , 2) most pronounced in the initial phase of weight loss (29) with no further reduction in liver size after 8 wk despite further losses in body weight and fat mass (54) , and 3) did not correlate with the decreases in total body fat (29, 55) or cross-sectional visceral fat area (29) . However, contrary to our study, morbidly obese individuals were investigated who were likely to have a high prevalence of hepatic steatosis as well as larger initial liver mass and thus greater weight loss-associated losses in liver mass. Our data show a high variance in liver fat content (0.4-30.4%), which decreased with weight loss (see Results).
Study limitations
Modeling REE from detailed body-composition analysis involves several assumptions that may have affected our results. First, muscle mass was calculated from lean soft tissue of arms and legs measured by dual-energy X-ray absorptiometry by using the equation of Kim et al (38) . Although this equation was derived from skeletal muscle mass measured by MRI, the acknowledged reference method, it was not validated in severely obese subjects because the study population included subjects with a BMI ,35 only. In our study population, 20 women had a BMI . 35 .
A second limitation of our model was the use of constant tissue densities adopted from the literature (31) . In obesity, ectopic liver fat would decrease hepatic density and thus lead to an overestimation of metabolically active liver mass in hepatic steatosis. In our subgroup of women who had an examination of liver fat, '85% of loss in liver mass was explained by the loss in liver fat. This would contribute to an overestimation of 55 kJ/d in adaptive thermogenesis (0.066 kg loss in liver fat · 840 kJ Á d 21 Á kg 21 specific metabolic rate of the liver). Likewise, a depletion of liver glycogen stores during the low-calorie diet may have contributed to the reduction in liver volume in our subjects. Assuming a glycogen content of '100 g in healthy subjects and a hydration of 3-4 g water per g glycogen (56), a depletion of glycogen would also contribute to a relative overestimation of metabolic liver mass at baseline when compared with after weight loss.
Conclusions
In conclusion, after weight loss, almost 50% of the decrease in REEm can be explained by losses of FFM and FM. The variability in REEm explained by body composition increased to 60% after the weight of individual organs was considered. However, adaptive thermogenesis after weight loss remained significant after the decrease in individual organ masses were accounted for. High adaptive thermogenesis is associated with lower weight loss and a conservation of visceral organ mass.
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